Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition.
about
Epigenetic regulation in cardiac fibrosisEndocardial and epicardial epithelial to mesenchymal transitions in heart development and diseaseRegulation of endothelial cell plasticity by TGF-βThrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overloadGlobal gene expression profiling in PAI-1 knockout murine heart and kidney: molecular basis of cardiac-selective fibrosisRecombinant PAI-1 therapy restores myoendothelial junctions and erectile function in PAI-1-deficient mice.TRB3 gene silencing alleviates diabetic cardiomyopathy in a type 2 diabetic rat modelMiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis.Proteases Revisited: Roles and Therapeutic Implications in Fibrosis.Heart failure with preserved ejection fraction: molecular pathways of the aging myocardiumDifferential regenerative capacity of neonatal mouse hearts after cryoinjury.Aging and Cardiac Fibrosis.Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungsBinding of anti-SSA antibodies to apoptotic fetal cardiocytes stimulates urokinase plasminogen activator (uPA)/uPA receptor-dependent activation of TGF-β and potentiates fibrosis.Matricellular proteins in cardiac adaptation and disease.Phenolic secoiridoids in extra virgin olive oil impede fibrogenic and oncogenic epithelial-to-mesenchymal transition: extra virgin olive oil as a source of novel antiaging phytochemicals.Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease.Matrix metalloproteinase 9 induces endothelial-mesenchymal transition via Notch activation in human kidney glomerular endothelial cellsVEGF dose regulates vascular stabilization through Semaphorin3A and the Neuropilin-1+ monocyte/TGF-β1 paracrine axisFGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression.ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy.Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease.Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.Plasminogen activator inhibitor-1 deficiency augments visceral mesothelial organization, intrapleural coagulation, and lung restriction in mice with carbon black/bleomycin-induced pleural injury.uPA binding to PAI-1 induces corneal myofibroblast differentiation on vitronectin.PAI-1 in tissue fibrosis.This is not Dr. Conn's aldosterone anymore.Molecular basis of organ fibrosis: potential therapeutic approaches.Transforming growth factor β--at the centre of systemic sclerosis.Cardiac fibrosis in the ageing heart: contributors and mechanisms.The Vascular Wall: a Plastic Hub of Activity in Cardiovascular Homeostasis and Disease.Roles of TGF-β signals in endothelial-mesenchymal transition during cardiac fibrosisRelationship between plasma plasminogen activator inhibitor-1 and hypertension in American Indians: findings from the Strong Heart Study.The mechanism of TGF-β/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells.A small molecule inhibitor of PAI-1 protects against doxorubicin-induced cellular senescence.Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT.Genomic biomarkers for cardiotoxicity in rats as a sensitive tool in preclinical studies.Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.Earlier onset of diabesity-Induced adverse cardiac remodeling in female compared to male mice.
P2860
Q26774536-20DA266E-89C6-48CE-977A-8345B2B72121Q26830155-43405823-DB06-4A0F-8DAF-2CF2F450A299Q26862059-6AD9DA23-8A2E-405E-B4D6-0773A7CD5F43Q28507674-B57025EA-C890-401D-91A0-AECD290D20F2Q28533371-E8F4AF45-8CB4-4381-A41B-B1E2B4A7D25BQ30301012-BD2C33BF-B540-47D9-B413-062A3C41415FQ30461459-D5A5ADC4-9FE4-46B6-8B9A-A4298B6097ABQ33731819-D6FF55A6-5940-426F-B6FD-CED1CEDE7DDFQ33795055-A2AFE385-71B5-4B64-87E4-380A297C0913Q33889242-80FD5DEC-8DE9-40CC-9BF5-E8C4006BFF6AQ35118442-AA3A43D4-3E21-40DC-8CDB-DE6D63F970A1Q35155965-308A473B-EE1D-48C9-86B8-CAEC0ABE913BQ35351530-EA91F861-6249-4180-B6EC-0CAC70C70AA0Q35522644-0B69E957-9096-4C98-AC8D-FE851B255C02Q35542423-5D1B0A61-A068-4BB1-975B-58306A832A15Q35770306-AECCF685-46DD-45F4-AEB3-88357D3DC6F4Q35906030-F94C3918-2938-44EC-BF57-F5EB3E5F3C67Q36004045-D3DBCC81-95DE-47C6-8565-61BBC21F25DFQ36159478-BC3C84B2-AC81-4FD5-A827-863186A52A6FQ36501648-F5956C28-0F0F-4DA4-93A0-A30B94939C11Q36542481-F161DB08-12E5-4FEC-85D5-FBD04B199CFAQ36908409-A803DC92-3D39-4B16-97F2-B706C9588EE0Q37580301-B62E5954-44AE-4526-94B0-D4FF3EFF0FA0Q37596163-0C60CCBD-91ED-4BE6-A907-0B62D08D7454Q37629834-D875945C-242A-48CB-850F-BBE34C018393Q37861626-8AFE134B-F900-4256-9D27-9D0EC9349FE2Q37891697-4F884CC8-DD68-4B4E-82AA-C0D39DF351DDQ38121751-DD0B1D8B-8BD2-4614-9EF0-A013AF9A0851Q38241227-31098362-ECB4-4290-9D52-ACE681EB7C95Q39186232-28A0B2AC-BDBC-4204-9E68-B0DEE850482BQ39255920-195B3509-6442-430C-A2DC-4CB5B430AC7BQ39725895-68C587F6-6332-4A5F-9710-B888FA8DDDDDQ40256787-760C52BA-C7E2-4DCC-B2E3-D9C30ADF7B5EQ41504730-B1CD4BEF-D015-4120-96F6-243A12CAEA77Q41841556-264F74C5-07D0-4453-A14E-CA98197FF7F6Q42273281-3901FC95-438A-430B-9E9A-11C163C119C8Q42590202-3E68D680-8DC4-4DC7-9A2D-A2625DF2210EQ42712058-918B5C89-AB72-420B-916E-393B3AC66FF8Q45868567-692A5F04-D222-495E-B302-E6AB2808B92AQ46730696-4F34E101-477D-4765-B347-F713C8793123
P2860
Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Genetic deficiency of plasmino ...... ial-to-mesenchymal transition.
@en
Genetic deficiency of plasmino ...... ial-to-mesenchymal transition.
@nl
type
label
Genetic deficiency of plasmino ...... ial-to-mesenchymal transition.
@en
Genetic deficiency of plasmino ...... ial-to-mesenchymal transition.
@nl
prefLabel
Genetic deficiency of plasmino ...... ial-to-mesenchymal transition.
@en
Genetic deficiency of plasmino ...... ial-to-mesenchymal transition.
@nl
P2093
P1433
P1476
Genetic deficiency of plasmino ...... ial-to-mesenchymal transition.
@en
P2093
Asish K Ghosh
Bart De Taeye
Douglas E Vaughan
Joseph W Covington
Linda A Gleaves
Sheila B Murphy
William S Bradham
P304
P356
10.1161/CIRCULATIONAHA.110.955245
P407
P577
2010-09-07T00:00:00Z